The role of intestinal bacterial microbiota has been described as key in the pathophysiology
of Crohn's disease (CD). CD is characterized by frequent relapses after periods of remission …

Background Microbial shifts have been associated with disease activity in Crohn's disease
[CD], but findings on specific taxa are inconsistent. This may be due to differences in applied …

Monitoring mucosal inflammation is crucial to prevent complications and disease
progression in Crohn's disease (CD). Endoscopy is the current standard, but is invasive …

BACKGROUND The dysbiosis of the gut microbiome is evident in Crohn's disease (CD)
compared with healthy controls (HC), although the alterations from active CD to remission …

Background Emerging evidence suggests that gut microbiota plays a predominant role in
Crohn's disease (CD). However, the microbiome alterations in the early stage of CD patients …

Background Bacteria might play a role in the pathogenesis of Crohn's disease (CD), and
patients harbor a different type and density of gut microbiota compared with normal healthy …

Inflammatory bowel disease (IBD) is a chronic, relapsing, inflammatory disorder which
comprises two main conditions: Crohn's disease (CD) and ulcerative colitis (UC). Although …

OBJECTIVES: Crohn's disease (CD) is a chronic relapsing-remitting gut inflammatory
disorder with a heterogeneous unpredictable course. Dysbiosis occurs in CD; however …

Background and Aim C rohn's disease pathogenesis involves alterations in the gut
microbiota. We characterized the mucosa‐associated microbiota at the time of surgical …

Background Limited studies have examined the intestinal microbiota composition in relation
to changes in disease course of IBD over time. We aimed to study prospectively the fecal …